STING1 and neoplasm: A single IP or IV injection of pHLIP-STING into mice bearing CT26 tumors (~100 mm3) triggers complete tumor eradication (90% incidence rate) and the mice remained tumor-free for 60 days after pHLIP-STINGa administration.